Predicting Amyloid-β Levels in Amnestic Mild Cognitive Impairment Using Machine Learning Techniques

BACKGROUND: Amyloid-β positivity (Aβ+) based on PET imaging is part of the enrollment criteria for many of the clinical trials of Alzheimer’s disease (AD), particularly in trials for amyloid-targeted therapy. Predicting Aβ positivity prior to PET imaging can decrease unnecessary patient burden and c...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Alzheimers Dis
Asıl Yazarlar: Ezzati, Ali, Harvey, Danielle J., Habeck, Christian, Golzar, Ashkan, Qureshi, Irfan A., Zammit, Andrea R., Hyun, Jinshil, Truelove-Hill, Monica, Hall, Charles B., Davatzikos, Christos, Lipton, Richard B.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7376527/
https://ncbi.nlm.nih.gov/pubmed/31884486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-191038
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller